v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 272,411 $ 121,699
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 48,011 34,613
Amortization of debt issuance costs and non-cash interest 342 472
Gain on disposal of property and equipment (1,243) (1,340)
Changes in the fair value of earn-outs 4,976 2,686
Distribution of earnings from unconsolidated subsidiaries 10,813 10,319
Equity in earnings from unconsolidated subsidiaries (6,573) (5,677)
Deferred taxes 6,265 5,414
Stock-based compensation 15,639 12,278
Changes in operating assets and liabilities (Note 15) (22,620) (10,153)
Net cash provided by operating activities 328,021 170,311
Cash flows from investing activities:    
Acquisitions, net of cash acquired (139,985) (37,860)
Capital expenditures (69,646) (31,262)
Proceeds from sale of property and equipment 3,132 2,645
Net cash used in investing activities (206,499) (66,477)
Cash flows from financing activities:    
Repayments of debt (7,577) (17,275)
Capital contributions from noncontrolling interest owners 14,700 0
Repurchase of common stock (35,256) (43,846)
Withholding taxes paid on net share settlement of equity awards (11,892) (6,126)
Payments of earn-outs (7,767) 0
Debt issuance costs 0 (1,409)
Net cash used in financing activities (47,792) (68,656)
Net change in cash, cash equivalents, and restricted cash 73,730 35,178
Cash, cash equivalents and restricted cash at beginning of period 390,721 664,195
Cash, cash equivalents and restricted cash at end of period 464,451 699,373
Less: restricted cash 0 0
Cash and cash equivalents at end of period 464,451 699,373
Non-cash items:    
Accrued capital expenditures 2,109 1,932
Share consideration for acquisitions 27,406 0
Insurance premiums financed through short-term financing agreement $ 10,646 $ 0